Come up with a name for your new list and we'll add to it:
Enobia Pharma raised a round of funding on March 28, 2009. Investors include
Qualifying Therapeutic Discovery Project.
Enobia Pharma develops therapies to treat serious genetic bone disorders for which there are no approved treatments. The company's lead product, ENB-0040 (human recombinant tissue non-specific alkalin…